论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
中国老年女性高血清 Chemerin 与骨矿物质密度损失和骨质疏松性骨折的关系
Authors Jiang XY, Wang Q, Zhang Y, Chen Y, Wu LF
Received 12 October 2021
Accepted for publication 29 December 2021
Published 2 February 2022 Volume 2022:14 Pages 107—118
DOI https://doi.org/10.2147/IJWH.S337985
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Everett F Magann
Background: Chemerin has been suggested to be a risk factor for osteoporosis; however, its relationship with osteoporotic fracture is poorly understood. Herein, we intend to explore the association between serum chemerin and osteoporotic fracture.
Methods: A total of 111 elderly women patients diagnosed with osteoporotic fracture were selected as the observation group, and 40 healthy subjects were enrolled as controls. Dual-energy X-ray absorptiometry, enzyme-linked immunosorbent assay, electrochemiluminescence immunoassay, and biochemical analysis were separately performed to determine body bone mineral density (BMD), chemerin levels, bone turnover markers, and other parameters. Pearson’s correlation analysis was conducted to examine a relationship between chemerin and laboratory parameters. Moreover, the levels of chemokine-like receptor 1 (CMKLR ), C-C motif chemokine receptor-like 2 (CCRL2 ), collagen type I alpha (COLA1), and runt-related transcription factor-2 (RUNX2 ) were confirmed by quantitative polymerase chain reaction, and the effect of chemerin on osteogenic differentiation of hFOB1.19 cells was indicated by tartrate-resistant acid phosphatase and alkaline phosphatase double staining.
Results: A higher level of chemerin was generally detected in patients with osteoporotic fracture compared with those without (P < 0.05). Compared with controls, lower BMD levels and higher β-CTx and P1NP levels were detected in patients with osteoporotic fracture (all P < 0.05). Interestingly, chemerin level was negatively correlated to BMD, but positively related to P1NP and β-CTx. Risk of osteoporotic fracture was 2.75-fold higher in subjects with each standard deviation increment of chemerin. Compared with controls, there were no significant differences in CMKLR1 and CCRL2 mRNA after incubation with osteogenic differentiation medium (all P > 0.05), whereas there was a remarkable decrease of COLA1 and RUNX2 after incubation with chemerin for nine days (all P < 0.05). Furthermore, prolonged incubation with chemerin enhanced osteoclast differentiation and maturation, consequently contributing to an increased risk of fracture.
Conclusion: Chemerin is a strong and independent risk factor for osteoporosis-related fracture among elderly Chinese women.
Keywords: chemerin, osteoporotic fracture, risk factor, elderly women